(Q53585495)

English

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

scientific article published on 28 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/24687454

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

chemiluminescence

1 reference

based on heuristic

inferred from title

author name string

Juan-Ping Yu

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Xi-Guang Xu

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Rui-Juan Ma

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Shi-Ni Qin

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Cong-Rong Wang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Xiao-Bo Wang

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Ming Li

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Ming-Song Li

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Qiang Ma

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Wei-Wen Xu

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

publication date

28 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/24687454

Journal of Clinical Laboratory Analysis

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

29

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

85-93

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Glypican-3: a new target for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Preparation and characterization of monoclonal antibody against glypican-3.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Early HCC: diagnosis and molecular markers

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21733

21 January 2018

Translational Research: Getting the message across

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A concise review of serum markers for hepatocellular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and expression of MXR7 gene in human HCC tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24687454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JCLA.21733

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6806998&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53585495&oldid=1422233574"